Page 124 - Ciences News Today

LONDON, Dec. 29, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd ("Tiziana", NASDAQ: TLSA), a biotechnology company enabling breakthrough CNS immunomodulation approaches to enhance the functionality

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - December 29, 2022) - BioHarvest Sciences Inc.("BioHarvest" or the "Company") (CSE: BHSC) (OTCQB: CNVCF) is pleased to provide the following

By Denny Jacob Gilead Sciences Inc. on Tuesday said it will acquire all outstanding rights of Jounce Therapeutics Inc. to GS-1811 following an amended license agreement for the antibody. ... | December 27, 2022

🔥 Compatibility To confirm that this part fits your vehicle, please enter your vehicles details below. ...<br>

Advancing pipeline of next generation therapeutics and diagnostics for oncology and immune diseases of high unmet needLONDON, Dec. 27, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd ("Tiziana", NASDAQ:

Quantori Develops Solutions on the Databricks Lakehouse Platform, Providing Real-Time Insights on Real World Data for Researchers and Clinicians to Improve Patient Outcomes Quantori, LLC, a leading

🔥 Compatibility To confirm that this part fits your vehicle, please enter your vehicles details below. ...<br>

FOSTER CITY (dpa-AFX) - The U.S. Food and Drug Administration approved Gilead Sciences Inc.'s (GILD) Sunlenca (lenacapavir), a new type of antiretroviral medication for adult patients living with

🔥 Compatibility To confirm that this part fits your vehicle, please enter your vehicles details below. ...<br>

- This two-part phase 1 trial in healthy volunteers was designed to assess the safety, pharmacokinetics, and analgesic activity of KUR-101 - KUR-101 was well tolerated and demonstrated analgesic